Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Todd Pitts

Concepts (400)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
24
2024
777
2.760
 Why?
Xenograft Model Antitumor Assays
38
2024
870
1.920
 Why?
Protein Kinase Inhibitors
19
2020
907
1.800
 Why?
Triple Negative Breast Neoplasms
7
2024
198
1.390
 Why?
Antineoplastic Agents
25
2020
2152
1.380
 Why?
Azepines
5
2024
97
1.340
 Why?
Histone Deacetylase Inhibitors
5
2024
209
1.200
 Why?
Cell Line, Tumor
38
2025
3392
1.140
 Why?
Pyrimidines
9
2020
472
1.130
 Why?
Mice, Nude
25
2024
688
1.110
 Why?
Pancreatic Neoplasms
7
2025
857
0.980
 Why?
Pyrazines
6
2018
87
0.980
 Why?
Carcinoma, Pancreatic Ductal
3
2025
267
0.970
 Why?
Cell Proliferation
22
2024
2480
0.920
 Why?
Apoptosis
22
2024
2546
0.750
 Why?
Fluorouracil
1
2022
204
0.720
 Why?
Proto-Oncogene Proteins
6
2018
620
0.620
 Why?
Benzimidazoles
6
2024
181
0.610
 Why?
Aurora Kinase A
4
2020
55
0.610
 Why?
Camptothecin
5
2022
122
0.600
 Why?
Imidazoles
4
2018
239
0.600
 Why?
Drug Resistance, Neoplasm
12
2024
801
0.560
 Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1742
0.530
 Why?
Drug Synergism
4
2014
368
0.530
 Why?
Mice
42
2025
17814
0.520
 Why?
Neoplasms
9
2022
2681
0.480
 Why?
Cell Cycle Proteins
2
2018
616
0.480
 Why?
Cell Cycle Checkpoints
3
2019
95
0.470
 Why?
Hydroxamic Acids
3
2011
90
0.470
 Why?
Wnt Signaling Pathway
5
2024
196
0.460
 Why?
Deoxycytidine
3
2024
192
0.450
 Why?
Melanoma
5
2024
756
0.450
 Why?
Receptor, IGF Type 1
3
2013
64
0.450
 Why?
Animals
47
2025
37217
0.440
 Why?
Disease Models, Animal
11
2025
4315
0.440
 Why?
Pyrazoles
5
2018
425
0.430
 Why?
Gene Expression Regulation, Neoplastic
10
2024
1388
0.430
 Why?
Adrenocortical Carcinoma
3
2020
63
0.430
 Why?
Antimitotic Agents
1
2013
8
0.420
 Why?
Mitogen-Activated Protein Kinases
3
2014
316
0.420
 Why?
Tumor Microenvironment
5
2022
669
0.420
 Why?
Tumor Suppressor Protein p53
5
2024
525
0.410
 Why?
Molecular Targeted Therapy
3
2024
413
0.410
 Why?
Signal Transduction
18
2024
5086
0.400
 Why?
G2 Phase Cell Cycle Checkpoints
4
2022
44
0.400
 Why?
Cyclin-Dependent Kinases
1
2013
131
0.380
 Why?
Boronic Acids
2
2011
35
0.380
 Why?
TOR Serine-Threonine Kinases
2
2018
415
0.380
 Why?
Quinoxalines
4
2020
67
0.360
 Why?
Dasatinib
2
2024
56
0.350
 Why?
Gene Expression Profiling
8
2024
1746
0.340
 Why?
Colonic Neoplasms
2
2013
245
0.340
 Why?
Drug Screening Assays, Antitumor
5
2020
193
0.330
 Why?
Humans
68
2025
138651
0.330
 Why?
Biomarkers, Tumor
6
2018
1224
0.320
 Why?
Heterografts
3
2021
135
0.320
 Why?
Programmed Cell Death 1 Receptor
3
2025
252
0.310
 Why?
Oxidoreductases Acting on CH-CH Group Donors
2
2020
26
0.310
 Why?
Phosphatidylinositol 3-Kinases
6
2018
368
0.290
 Why?
Adrenal Cortex Neoplasms
2
2020
60
0.280
 Why?
Ephrin-B2
2
2019
45
0.280
 Why?
Cell Cycle
7
2018
592
0.270
 Why?
Enzyme Inhibitors
5
2020
847
0.270
 Why?
Piperazines
2
2020
345
0.270
 Why?
Quinazolines
3
2015
249
0.260
 Why?
Drug Delivery Systems
1
2010
359
0.260
 Why?
Antibodies, Monoclonal, Humanized
2
2024
815
0.250
 Why?
Anilides
2
2018
70
0.250
 Why?
Oncogene Proteins, Fusion
2
2018
203
0.250
 Why?
Mitogen-Activated Protein Kinase Kinases
3
2019
132
0.240
 Why?
Female
41
2025
73763
0.240
 Why?
Protein-Lysine 6-Oxidase
1
2025
14
0.240
 Why?
Gene Dosage
4
2015
141
0.230
 Why?
Organoids
2
2024
119
0.230
 Why?
Mutation
9
2018
3987
0.230
 Why?
Nephritis, Interstitial
1
2025
12
0.230
 Why?
Immunoblotting
6
2015
309
0.230
 Why?
Cyclosporine
2
2018
265
0.220
 Why?
Gene Regulatory Networks
2
2024
309
0.220
 Why?
Collagen Type I
1
2025
139
0.220
 Why?
Pyrimidinones
2
2015
114
0.220
 Why?
Proto-Oncogene Proteins B-raf
3
2018
222
0.220
 Why?
Lymphocytes, Tumor-Infiltrating
3
2020
205
0.210
 Why?
RNA, Small Interfering
2
2024
626
0.210
 Why?
ras Proteins
4
2013
148
0.210
 Why?
Proto-Oncogene Proteins p21(ras)
6
2016
262
0.210
 Why?
Endogenous Retroviruses
1
2024
38
0.210
 Why?
Bevacizumab
1
2024
139
0.210
 Why?
Receptor, Notch1
2
2015
65
0.210
 Why?
Mucous Membrane
1
2024
125
0.200
 Why?
Pyridones
2
2015
170
0.200
 Why?
Neoplasm Transplantation
4
2018
250
0.200
 Why?
Pyridines
2
2018
494
0.200
 Why?
Paclitaxel
1
2024
237
0.200
 Why?
Collagen
1
2025
459
0.190
 Why?
Antineoplastic Agents, Immunological
3
2020
190
0.190
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
65
0.190
 Why?
HCT116 Cells
3
2018
80
0.190
 Why?
Immunotherapy
3
2022
634
0.190
 Why?
Doxorubicin
1
2024
348
0.180
 Why?
Drug Design
2
2013
165
0.180
 Why?
beta Catenin
2
2020
252
0.180
 Why?
Gene Knockdown Techniques
4
2020
329
0.170
 Why?
Momordica charantia
1
2020
15
0.170
 Why?
DNA-Binding Proteins
2
2020
1471
0.160
 Why?
Benzoxazoles
1
2020
19
0.160
 Why?
HT29 Cells
2
2018
41
0.160
 Why?
Neoplasms, Experimental
2
2019
174
0.160
 Why?
Immune System
1
2021
181
0.160
 Why?
eIF-2 Kinase
1
2019
31
0.160
 Why?
src-Family Kinases
2
2017
93
0.150
 Why?
Receptor, EphB4
1
2019
33
0.150
 Why?
Inhibitory Concentration 50
2
2016
89
0.150
 Why?
DNA Helicases
1
2020
138
0.150
 Why?
Tumor Burden
2
2018
309
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.140
 Why?
Coenzymes
1
2018
19
0.140
 Why?
Plant Extracts
1
2020
207
0.140
 Why?
4-Aminobenzoic Acid
1
2018
8
0.140
 Why?
Thermodynamics
1
2020
422
0.140
 Why?
MAP Kinase Kinase Kinases
2
2015
72
0.140
 Why?
Neoplasm Proteins
2
2020
429
0.140
 Why?
Septins
1
2018
43
0.140
 Why?
Adrenal Cortex
1
2018
33
0.140
 Why?
Oncogene Proteins v-abl
1
2017
5
0.140
 Why?
Neoplasm Invasiveness
3
2020
501
0.140
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
35
0.130
 Why?
Angiogenesis Inhibitors
3
2018
230
0.130
 Why?
Kidney
1
2025
1466
0.130
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2014
85
0.130
 Why?
Skin Neoplasms
1
2024
837
0.130
 Why?
Ubiquitin-Activating Enzymes
1
2016
17
0.130
 Why?
Cyclopentanes
1
2016
19
0.130
 Why?
Transplantation, Heterologous
4
2022
192
0.130
 Why?
Tumor Cells, Cultured
4
2020
956
0.130
 Why?
Corynebacterium
1
2017
49
0.120
 Why?
Corynebacterium Infections
1
2017
42
0.120
 Why?
Tankyrases
1
2016
13
0.120
 Why?
Cetuximab
1
2016
98
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
325
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
122
0.120
 Why?
Capecitabine
1
2015
41
0.120
 Why?
Amyloid Precursor Protein Secretases
2
2013
79
0.120
 Why?
Autophagy
1
2018
285
0.120
 Why?
Biliary Tract Neoplasms
1
2015
29
0.120
 Why?
Drug Discovery
1
2016
144
0.120
 Why?
Genes, ras
2
2018
94
0.120
 Why?
Adenocarcinoma
2
2020
885
0.120
 Why?
Cell Survival
3
2019
1123
0.110
 Why?
Diphenylamine
1
2014
9
0.110
 Why?
Gene Expression Regulation
1
2024
2590
0.110
 Why?
DNA Copy Number Variations
1
2015
176
0.110
 Why?
Germ-Line Mutation
2
2018
166
0.110
 Why?
Proto-Oncogene Proteins c-met
1
2014
72
0.110
 Why?
Piperidines
1
2015
216
0.110
 Why?
Middle Aged
14
2024
33604
0.100
 Why?
Protein Kinases
1
2015
308
0.100
 Why?
Benzamides
1
2014
213
0.100
 Why?
Urinary Bladder Neoplasms
1
2016
254
0.100
 Why?
Up-Regulation
1
2016
851
0.100
 Why?
Receptor, Insulin
1
2013
100
0.100
 Why?
Tetrahydronaphthalenes
1
2013
30
0.100
 Why?
Valine
1
2013
77
0.100
 Why?
Aged
11
2024
24024
0.100
 Why?
Neutrophils
4
2019
1274
0.100
 Why?
Bortezomib
2
2011
53
0.100
 Why?
Receptors, Notch
1
2013
87
0.100
 Why?
Tumor Suppressor Proteins
1
2015
320
0.100
 Why?
Mitosis
1
2013
192
0.100
 Why?
Antineoplastic Agents, Phytogenic
1
2013
190
0.090
 Why?
3' Untranslated Regions
1
2012
145
0.090
 Why?
Head and Neck Neoplasms
1
2016
549
0.090
 Why?
Aldehyde Dehydrogenase
1
2012
100
0.090
 Why?
Carcinoma, Squamous Cell
1
2016
638
0.090
 Why?
Sirolimus
1
2013
277
0.090
 Why?
Proteasome Inhibitors
1
2011
43
0.090
 Why?
Computational Biology
1
2015
649
0.090
 Why?
Benzodioxoles
1
2012
116
0.090
 Why?
Protease Inhibitors
1
2011
105
0.080
 Why?
Carcinogenesis
2
2024
215
0.080
 Why?
Proto-Oncogene Proteins c-akt
4
2018
442
0.080
 Why?
Mice, Inbred NOD
2
2022
593
0.080
 Why?
Nuclear Proteins
1
2015
706
0.080
 Why?
Phosphorylation
4
2019
1760
0.080
 Why?
Neoplasm Metastasis
3
2018
666
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
7
0.080
 Why?
Adult
12
2024
38201
0.080
 Why?
Mice, Inbred BALB C
3
2020
1262
0.080
 Why?
Breast Neoplasms
2
2012
2212
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2009
72
0.080
 Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
97
0.070
 Why?
Gastrointestinal Neoplasms
1
2009
75
0.070
 Why?
Cell Movement
2
2011
969
0.070
 Why?
Male
15
2024
68260
0.070
 Why?
Positron-Emission Tomography
3
2018
304
0.070
 Why?
Immunosuppressive Agents
1
2013
849
0.070
 Why?
Carcinoma, Hepatocellular
1
2011
335
0.070
 Why?
Prognosis
4
2019
3984
0.070
 Why?
Farnesyltranstransferase
1
2007
35
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2015
761
0.060
 Why?
Protein Conformation
2
2020
936
0.060
 Why?
Gene Expression
2
2019
1488
0.060
 Why?
Microsatellite Repeats
2
2024
159
0.060
 Why?
Feasibility Studies
1
2010
980
0.060
 Why?
Maximum Tolerated Dose
2
2020
204
0.060
 Why?
Transcription, Genetic
2
2024
1470
0.060
 Why?
Algorithms
3
2024
1740
0.060
 Why?
Reproducibility of Results
2
2010
3307
0.060
 Why?
Quinolones
1
2007
135
0.060
 Why?
Ipilimumab
1
2025
32
0.060
 Why?
Neovascularization, Pathologic
2
2018
296
0.060
 Why?
Disease Progression
2
2025
2749
0.050
 Why?
CTLA-4 Antigen
1
2025
98
0.050
 Why?
Models, Molecular
2
2020
1587
0.050
 Why?
Structure-Activity Relationship
2
2018
575
0.050
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2019
40
0.050
 Why?
Triazoles
1
2024
156
0.050
 Why?
Enhancer Elements, Genetic
1
2024
189
0.050
 Why?
HMGB1 Protein
1
2003
50
0.050
 Why?
Proto-Oncogene Proteins c-raf
1
2002
44
0.050
 Why?
Adrenergic alpha-Agonists
1
2002
28
0.050
 Why?
Adrenergic alpha-Antagonists
1
2002
34
0.050
 Why?
Neuroimmunomodulation
1
2002
66
0.050
 Why?
Magnetic Resonance Spectroscopy
2
2018
613
0.050
 Why?
Histone Deacetylase 1
1
2022
20
0.050
 Why?
Isoenzymes
1
2003
303
0.050
 Why?
Adrenergic beta-Agonists
1
2002
97
0.050
 Why?
Aurora Kinases
2
2012
28
0.050
 Why?
Histones
2
2022
632
0.050
 Why?
Treatment Outcome
4
2024
10923
0.050
 Why?
Endotoxemia
1
2002
87
0.050
 Why?
Genetic Predisposition to Disease
1
2010
2339
0.040
 Why?
Caspase 3
2
2013
249
0.040
 Why?
Acetylation
1
2022
244
0.040
 Why?
Chimerism
1
2021
32
0.040
 Why?
Extracellular Matrix
1
2025
541
0.040
 Why?
Adrenergic beta-Antagonists
1
2002
228
0.040
 Why?
Flow Cytometry
2
2019
1192
0.040
 Why?
Campylobacter jejuni
1
2000
13
0.040
 Why?
Lymphocyte Subsets
1
2021
88
0.040
 Why?
Lymphoid Tissue
1
2021
79
0.040
 Why?
Cluster Analysis
2
2012
517
0.040
 Why?
Catalase
1
2000
134
0.040
 Why?
TCF Transcription Factors
1
2020
17
0.040
 Why?
Histone Deacetylases
1
2022
209
0.040
 Why?
RNA, Neoplasm
1
2020
79
0.040
 Why?
Mice, SCID
1
2021
368
0.040
 Why?
Antimetabolites, Antineoplastic
1
2020
92
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Indolizines
1
2019
4
0.040
 Why?
Forkhead Box Protein M1
1
2019
7
0.040
 Why?
Small Molecule Libraries
1
2020
94
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
129
0.040
 Why?
MAP Kinase Kinase 2
2
2013
28
0.040
 Why?
Genomics
1
2024
796
0.040
 Why?
MAP Kinase Kinase 1
2
2013
75
0.040
 Why?
Crystallography, X-Ray
1
2020
477
0.040
 Why?
Genetic Linkage
1
1999
288
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
High-Throughput Screening Assays
1
2020
155
0.040
 Why?
Flavin-Adenine Dinucleotide
1
2018
17
0.040
 Why?
NADP
1
2018
53
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
210
0.040
 Why?
Multifactorial Inheritance
1
1999
170
0.030
 Why?
Nausea
1
2018
111
0.030
 Why?
Radiotherapy
1
2019
207
0.030
 Why?
Aldosterone
1
2018
42
0.030
 Why?
Kaplan-Meier Estimate
1
2020
896
0.030
 Why?
Drug Therapy, Combination
1
2020
1032
0.030
 Why?
Area Under Curve
1
2018
319
0.030
 Why?
Breast
1
2018
158
0.030
 Why?
Hemorrhage
1
2002
747
0.030
 Why?
DNA Damage
1
2020
422
0.030
 Why?
Catalytic Domain
1
2018
220
0.030
 Why?
Diarrhea
1
2018
183
0.030
 Why?
RNA
1
2024
925
0.030
 Why?
Recombinant Proteins
1
2020
1352
0.030
 Why?
Autistic Disorder
1
1999
206
0.030
 Why?
Disease-Free Survival
1
2018
704
0.030
 Why?
Axin Protein
1
2016
19
0.030
 Why?
Ubiquitination
1
2016
105
0.030
 Why?
Fatigue
1
2018
336
0.030
 Why?
Hypertension
2
2018
1242
0.030
 Why?
RNA, Messenger
2
2020
2815
0.030
 Why?
T-Lymphocytes, Regulatory
1
2019
386
0.030
 Why?
Protein Isoforms
1
2017
395
0.030
 Why?
Administration, Oral
1
2018
788
0.030
 Why?
Sequence Analysis, RNA
1
2018
448
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
23
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Gene Duplication
1
2015
65
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
661
0.030
 Why?
Binding Sites
1
2018
1313
0.030
 Why?
Biopsy
1
2018
1072
0.030
 Why?
NF-kappa B
3
2003
678
0.030
 Why?
Immunohistochemistry
1
2019
1731
0.030
 Why?
Databases, Genetic
1
2015
241
0.030
 Why?
Calcium-Binding Proteins
1
2015
215
0.030
 Why?
Mice, Knockout
1
2021
3028
0.030
 Why?
Caspase 7
1
2013
22
0.030
 Why?
Butadienes
1
2013
37
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
385
0.030
 Why?
Cell Growth Processes
1
2013
53
0.030
 Why?
Survival Analysis
1
2016
1309
0.030
 Why?
Tumor Stem Cell Assay
1
2012
34
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2019
905
0.020
 Why?
Everolimus
1
2013
110
0.020
 Why?
Nitriles
1
2013
176
0.020
 Why?
Phenotype
1
2021
3139
0.020
 Why?
Random Allocation
1
2013
363
0.020
 Why?
Immunoprecipitation
1
2012
154
0.020
 Why?
Cyclic AMP Response Element-Binding Protein
2
2003
145
0.020
 Why?
Neoplasm Staging
1
2015
1372
0.020
 Why?
p38 Mitogen-Activated Protein Kinases
2
2003
280
0.020
 Why?
Calcium Signaling
1
2013
250
0.020
 Why?
Kinetics
1
2014
1645
0.020
 Why?
Enzyme Activation
2
2003
810
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2012
310
0.020
 Why?
PTEN Phosphohydrolase
1
2012
163
0.020
 Why?
Cellular Senescence
1
2012
191
0.020
 Why?
Li-Fraumeni Syndrome
1
2010
14
0.020
 Why?
Receptor, ErbB-2
1
2012
346
0.020
 Why?
Molecular Epidemiology
1
2010
72
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
159
0.020
 Why?
Population Groups
1
2010
58
0.020
 Why?
Neutropenia
1
2010
157
0.020
 Why?
Ki-67 Antigen
1
2010
111
0.020
 Why?
Ligands
1
2011
665
0.020
 Why?
Capillary Permeability
1
2010
147
0.020
 Why?
Metabolome
1
2013
352
0.020
 Why?
Drug Combinations
1
2010
346
0.020
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
344
0.020
 Why?
Keratinocytes
1
2010
251
0.020
 Why?
Transcriptome
1
2015
967
0.020
 Why?
Australia
1
2010
305
0.020
 Why?
Membrane Proteins
1
2015
1145
0.020
 Why?
Antibodies, Monoclonal
1
2015
1436
0.020
 Why?
Biomarkers
1
2019
4092
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
984
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2007
14
0.020
 Why?
Sulfonamides
1
2011
505
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
849
0.020
 Why?
Calcium
1
2013
1180
0.020
 Why?
Verapamil
1
2007
40
0.020
 Why?
Blotting, Western
1
2009
1230
0.020
 Why?
Clone Cells
1
2007
265
0.020
 Why?
Dose-Response Relationship, Drug
1
2010
2049
0.020
 Why?
Magnetic Resonance Imaging
1
2018
3637
0.020
 Why?
Calcium Channel Blockers
1
2007
172
0.010
 Why?
Family
1
2010
677
0.010
 Why?
MicroRNAs
1
2012
675
0.010
 Why?
Metabolomics
1
2011
689
0.010
 Why?
Cohort Studies
1
2015
5697
0.010
 Why?
Liver Neoplasms
1
2011
712
0.010
 Why?
Ovarian Neoplasms
1
2010
562
0.010
 Why?
Phosphotransferases
1
2003
24
0.010
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
3
0.010
 Why?
bcl-Associated Death Protein
1
2003
9
0.010
 Why?
Phentolamine
1
2002
18
0.010
 Why?
Ribosomal Protein S6 Kinases
1
2002
25
0.010
 Why?
Brimonidine Tartrate
1
2002
10
0.010
 Why?
Propranolol
1
2002
45
0.010
 Why?
Phenylephrine
1
2002
75
0.010
 Why?
Mice, Mutant Strains
1
2003
309
0.010
 Why?
Adolescent
2
2018
21564
0.010
 Why?
Chemokines
1
2003
226
0.010
 Why?
Peroxidase
1
2002
182
0.010
 Why?
Mitogen-Activated Protein Kinase 3
1
2002
150
0.010
 Why?
Biological Transport
1
2003
403
0.010
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2003
234
0.010
 Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
129
0.010
 Why?
Young Adult
1
2018
13305
0.010
 Why?
Respiratory Burst
1
2000
19
0.010
 Why?
omega-N-Methylarginine
1
2000
31
0.010
 Why?
MAP Kinase Signaling System
1
2002
322
0.010
 Why?
Inflammation Mediators
1
2003
513
0.010
 Why?
Protein Processing, Post-Translational
1
2002
462
0.010
 Why?
Statistical Distributions
1
1999
8
0.010
 Why?
Cloning, Molecular
1
2000
533
0.010
 Why?
Matched-Pair Analysis
1
1999
38
0.010
 Why?
Intelligence Tests
1
1999
61
0.010
 Why?
Chromosomes, Human
1
1999
44
0.010
 Why?
Nuclear Family
1
1999
57
0.010
 Why?
Lipopolysaccharides
1
2003
888
0.010
 Why?
Protein-Tyrosine Kinases
1
2002
431
0.010
 Why?
Hydrogen Peroxide
1
2000
331
0.010
 Why?
Linkage Disequilibrium
1
1999
255
0.010
 Why?
Carrier Proteins
1
2003
737
0.010
 Why?
Models, Genetic
1
1999
590
0.010
 Why?
Cells, Cultured
1
2003
4181
0.010
 Why?
Cytokines
1
2003
2080
0.010
 Why?
Cell Line
1
2000
2876
0.010
 Why?
Molecular Sequence Data
1
1999
2923
0.010
 Why?
Genotype
1
1999
1842
0.010
 Why?
Sex Factors
1
1999
2044
0.010
 Why?
Macrophages
1
2000
1543
0.010
 Why?
Mice, Inbred C57BL
1
2003
5798
0.010
 Why?
Child, Preschool
1
1999
11158
0.000
 Why?
Child
1
1999
21921
0.000
 Why?
Pitts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (400) concept(s)
_
Co-Authors Expand Description
See all (87) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)